Protalix BioTherapeutics
PLX
#8763
Rank
C$0.23 B
Marketcap
C$2.86
Share price
1.98%
Change (1 day)
-8.49%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): C$0.02393

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is C$0.02780. In 2024 the company made an earnings per share (EPS) of C$0.05559 a decrease over its 2023 EPS that were of C$0.17.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.02393-56.96%
2024C$0.05559-66.67%
2023C$0.17-138.71%
2022C-$0.43-50%
2021C-$0.86181.82%
2020C-$0.31-82.11%
2019C-$1.71-31.67%
2018C-$2.50-72.31%
2017C-$9.03124.14%
2016C-$4.03-147.54%
2015C$8.48-290.63%
2014C-$4.456.67%
2013C-$4.17130.77%
2012C-$1.81-69.77%
2011C-$5.9819.44%
2010C-$5.00-12.2%
2009C-$5.7036.67%
2008C-$4.17-37.5%
2007C-$6.6750%
2006C-$4.453.23%
2005C-$4.31138.46%
2004C-$1.81-74%
2003C-$6.95-0%
2002C-$6.95-50%
2001C-$13.90233.33%
2000C-$4.17-84.21%
1999C-$26.41-24%
1998C-$34.75-600%
1997C$6.95-16.67%
1996C$8.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
C-$0.15-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$5.99 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.39 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.88 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel